Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
Clinical trial NCT04840485 · COMPLETED
Trial details
- NCT number
- NCT04840485
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2023-11-03
- Enrollment
- 548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.